Simplex Trading’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $10.4M | Buy |
166,646
+66,461
| +66% | +$4.2M | 0.01% | 748 |
|
|
2026
Q2 | $5.77M | Buy |
+100,185
| New | +$5.75M | ﹤0.01% | 1105 |
|
|
2025
Q4 | – | Sell |
-256,777
| Closed | -$12.4M | – | 8602 |
|
|
2025
Q3 | $11.6M | Buy |
256,777
+192,084
| +297% | +$8.97M | 0.01% | 872 |
|
|
2025
Q2 | $2.99M | Sell |
64,693
-124,206
| -66% | -$6.1M | ﹤0.01% | 1762 |
|
|
2025
Q1 | $11.5M | Sell |
188,899
-147,729
| -44% | -$8.61M | 0.01% | 801 |
|
|
2024
Q4 | $19M | Sell |
336,628
-14,458
| -4% | -$808K | 0.01% | 667 |
|
|
2024
Q3 | $18.2M | Sell |
351,086
-206,925
| -37% | -$9.7M | 0.01% | 687 |
|
|
2024
Q2 | $23.2M | Buy |
558,011
+54,263
| +11% | +$2.43M | 0.01% | 558 |
|
|
2024
Q1 | $27.3M | Buy |
+503,748
| New | +$25.7M | 0.02% | 548 |
|
|
2023
Q4 | – | Sell |
-182,593
| Closed | -$9.6M | – | 8793 |
|
|
2023
Q3 | $10.6M | Buy |
182,593
+93,234
| +104% | +$5.71M | 0.01% | 899 |
|
|
2023
Q2 | $5.71M | Buy |
+89,359
| New | +$5.99M | ﹤0.01% | 1228 |
|
|
2023
Q1 | – | Sell |
-210,946
| Closed | -$14.9M | – | 9042 |
|
|
2022
Q4 | $15.2M | Buy |
210,946
+23,361
| +12% | +$1.76M | 0.02% | 665 |
|
|
2022
Q3 | $13.3M | Sell |
187,585
-53,474
| -22% | -$3.88M | 0.02% | 667 |
|
|
2022
Q2 | $18.6M | Buy |
241,059
+240,884
| +137,648% | +$18.3M | 0.02% | 532 |
|
|
2022
Q1 | $12K | Sell |
175
-162,939
| -100% | -$10.9M | ﹤0.01% | 8717 |
|
|
2021
Q4 | $10.2M | Buy |
163,114
+65,017
| +66% | +$3.81M | 0.01% | 779 |
|
|
2021
Q3 | $6.53M | Sell |
98,097
-70
| -0.1% | -$4.61K | 0.01% | 993 |
|
|
2021
Q2 | $6.56M | Buy |
98,167
+15,427
| +19% | +$1.01M | 0.01% | 968 |
|
|
2021
Q1 | $5.22M | Sell |
82,740
-33,996
| -29% | -$2.12M | 0.01% | 786 |
|
|
2020
Q4 | $7.24M | Buy |
116,736
+94,467
| +424% | +$5.81M | 0.01% | 742 |
|
|
2020
Q3 | $1.34M | Sell |
22,269
-167,000
| -88% | -$10.1M | ﹤0.01% | 1917 |
|
|
2020
Q2 | $11.1M | Sell |
189,269
-166,733
| -47% | -$10M | 0.02% | 485 |
|
|
2020
Q1 | $19.8M | Buy |
356,002
+164,287
| +86% | +$10M | 0.04% | 239 |
|
|
2019
Q4 | $0 | Buy |
+191,715
| New | +$11M | ﹤0.01% | 7298 |
|
|
2019
Q3 | – | Sell |
-201,734
| Closed | -$9.48M | – | 7248 |
|
|
2019
Q2 | $9.15M | Buy |
201,734
+87,641
| +77% | +$4.08M | 0.03% | 429 |
|
|
2019
Q1 | $5.44M | Buy |
114,093
+9,772
| +9% | +$487K | 0.02% | 627 |
|
|
2018
Q4 | $5.42M | Buy |
104,321
+41,956
| +67% | +$2.25M | 0.02% | 528 |
|
|
2018
Q3 | $3.87M | Sell |
62,365
-40,046
| -39% | -$2.38M | 0.01% | 772 |
|
|
2018
Q2 | $5.67M | Sell |
102,411
-14,867
| -13% | -$803K | 0.02% | 516 |
|
|
2018
Q1 | $7.42M | Buy |
+117,278
| New | +$7.54M | 0.33% | 56 |
|
|
2017
Q3 | – | Sell |
-29,429
| Closed | -$1.72M | – | 5900 |
|
|
2017
Q2 | $1.64M | Buy |
+29,429
| New | +$1.6M | 0.07% | 213 |
|
|
2016
Q4 | – | Sell |
-49,802
| Closed | -$2.72M | – | 5841 |
|
|
2016
Q3 | $2.68M | Buy |
+49,802
| New | +$3.2M | 0.18% | 101 |
|
|
2015
Q4 | – | Sell |
-43,515
| Closed | -$2.88M | – | 5406 |
|
|
2015
Q3 | $2.58M | Buy |
43,515
+37,376
| +609% | +$2.37M | 0.19% | 91 |
|
|
2015
Q2 | $408K | Sell |
6,139
-1,966
| -24% | -$130K | 0.03% | 465 |
|
|
2015
Q1 | $522K | Buy |
+8,105
| New | +$507K | 0.06% | 321 |
|
Other funds holding BMY
Simplex Trading's BMY Position: Q3 2026 in Review
Simplex Trading increased its Bristol-Myers Squibb (BMY) stake by 66% in Q3 2026, buying an estimated $4.2M and bringing the position to 166,646 shares worth $10.4M. The position accounts for 0.01% of the portfolio, ranked #748.
Simplex Trading first reported a position in BMY in Q1 2015 and has held it in 35 quarters since. The position peaked at $27.3M in Q1 2024. 1,763 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Simplex Trading held 166,646 shares of Bristol-Myers Squibb worth $10.4M as of Q3 2026.
- Simplex Trading bought 66,461 Bristol-Myers Squibb shares in Q3 2026, an estimated $4.2M.
- Bristol-Myers Squibb made up 0.01% of Simplex Trading's portfolio in Q3 2026, its #748 holding.
- Simplex Trading first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 35 quarters since.
- Simplex Trading's Bristol-Myers Squibb position peaked at $27.3M in Q1 2024.
- 1,763 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.